Search

everythinglearnresearchcommunity

for

Search:↓

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Corrective hair repair surgery can significantly improve appearance and quality of life for patients with unsatisfactory results from old hair transplants.

The document concludes that regenerating functional ectodermal organs like teeth and hair is promising for future therapies.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Minoxidil, a common alopecia medication, might cause eye changes due to its properties and lack of tissue selectivity.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Cannabinoids may help treat various skin conditions.

Endocannabinoids help control mast cell activity in human skin.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Enhancing cannabinoid signaling may help treat skin inflammation.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Cell polarity signaling controls tissue mechanics and cell fate, with complex interactions and varying pathways across species.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.